1. CJC-1295 with Ipamorelin is a synergistic peptide combination
2. designed to stimulate natural growth hormone (GH) release
3. safely and effectively.
4. CJC-1295 promotes a steady, long-acting increase in GH by stimulating GHRH receptors, while
5. Ipamorelin specifically targets ghrelin receptors for rapid GH release without significantly
6. affecting appetite or cortisol levels.
7. Together, this duo enhances lean muscle growth, fat metabolism, recovery, and anti-aging
8. benefits, making it one of the most popular peptide therapies for overall performance, vitality,
9. and longevity.

Mechanism of Action:

1. CJC-1295: Stimulates pituitary GHRH receptors for sustained GH release
2. Increases circulating IGF-1 levels to support tissue repair and muscle growth
3. Ipamorelin: Selective ghrelin receptor agonist promoting GH pulses
4. Minimal effect on appetite, cortisol, or prolactin, offering a safer profile
5. Combined Effect: Mimics physiologic GH secretion patterns (pulsatile + sustained)
6. Enhances recovery, fat burning, and cellular regeneration

Ideal For:

1. Patients seeking growth hormone optimization without synthetic GH injections
2. Anti-aging and longevity support
3. Improved lean muscle development and fat metabolism
4. Faster recovery from training or injury
5. Enhanced sleep quality, energy, and cognitive performance

Dosage & Protocols:

1. Typical SubQ Dose: 0.1–0.2 mL (200–400 mcg of each peptide) per injection
2. Frequency: 1–2 times daily, often in the evening before sleep or post-exercise
3. Duration: 8–12 weeks, with provider monitoring and reassessment
4. Dosage should always be tailored under clinical supervision

Common Injection Sites:

SubQ: Lower abdomen, thigh, or triceps region